We could make solar panels on the moon by melting lunar dust
A boot print on the dusty surface of the moonPublic domain sourced / access rights from CBW / Alamy Future ...
Pulsed Field Ablation an Option to Prevent Recurrence of Atrial Tachyarrhythmia
(MedPage Today) -- Pulsed field ablation (PFA) was noninferior to cryoballoon ablation for the incidence of a first recurrence of ...
Rectal Probe Case Settled; Fake Plastic Surgeon Arrested; ‘Terror’ Doc Sentenced
(MedPage Today) -- Device company Prometheus, maker of rectal therapeutic systems and probes, will pay $550,000 to settle allegations that ...
Hundreds of Thousands of Health Workers at Risk of Deportation
(MedPage Today) -- More than 350,000 noncitizen healthcare workers in the U.S. may be at risk of deportation as part ...
SGLT2 Inhibitors Progressing to New Standard After TAVI
CHICAGO — For older patients at high risk for a heart failure event who are scheduled for transcatheter aortic valve ...
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Nearly 2 years after entering the market, adalimumab biosimilars are finally seeing traction.CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth ...
Trump Official Pauses Vax Decision; Doctor’s Speech Cancelled; Chocolate Bar Recall
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers ...
Second Pig Kidney Transplant Success and FDA Trial Approval
Nearly a year after performing the first transplant of a pig kidney into a living human recipient, Massachusetts General Hospital ...
Five-Year Data Support Pembro + CRT for NSCLC
Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients with unresectable, locally advanced, ...
State and Local Funding Cuts Hit ID Hard
In late March, the US Department of Health and Human Services announced the cancellation of more than $11 billion in ...
Trial Analysis Characterizes SCLC Disease Progression
Durvalumab consolidation therapy reduced the rate of extrathoracic metastases vs placebo and prolonged the time to progression or death due ...
US FDA Declines to Approve Aldeyra’s Eye Disease Drug
(Reuters) -The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, ...
TYK2 Inhibitors Show Impressive Efficacy for Psoriasis
ORLANDO, Fla. — In moderate to severe plaque psoriasis, two highly selective oral TYK2 inhibitors produced a level of response ...
Smartwatch Motivates Patients With Diabetes to Stay Active
TOPLINE: A recent study showed that a home-delivered physical activity intervention supported by wearable mobile health technology may help patients with ...
Women With Overactive Bladder Can Avoid Urodynamics Testing
TOPLINE:Urodynamics plus comprehensive clinical assessment (CCA) showed no superiority over CCA alone in treating women with refractory overactive bladder symptoms. ...
Ruxolitinib Shows Consistent Results Across Vitiligo Groups
TOPLINE:Ruxolitinib cream was well tolerated, and the application of the cream led to clinically meaningful repigmentation in patients with vitiligo ...
Pityriasis Rosea Before 15 Weeks May Up Pregnancy Risks
TOPLINE:In a review of pregnant patients with pityriasis rosea (PR), 19% experienced unfavorable outcomes, which were higher in cases that ...
When to Prescribe GLP-1s? Earlier Might Be Better
The US Preventive Services Task Force (USPSTF) recommends that patients trying to lose weight should first try 6 months of ...
New Canadian Guideline for Postpartum Physical Activity
During the first year after giving birth, mothers should work up to 120 min/wk of moderate to vigorous physical activity, ...
Are Healthcare Providers Ready to Tackle Partner Violence?
TOPLINE:More than 80% of Malaysian primary healthcare providers lacked training in intimate partner violence (IPV) management. Factors such as longer ...
